1. Home
  2. IOSP vs TSHA Comparison

IOSP vs TSHA Comparison

Compare IOSP & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Innospec Inc.

IOSP

Innospec Inc.

HOLD

Current Price

$79.88

Market Cap

1.8B

Sector

Industrials

ML Signal

HOLD

Logo Taysha Gene Therapies Inc.

TSHA

Taysha Gene Therapies Inc.

HOLD

Current Price

$4.61

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IOSP
TSHA
Founded
1938
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
1998
2020

Fundamental Metrics

Financial Performance
Metric
IOSP
TSHA
Price
$79.88
$4.61
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
9
Target Price
$124.00
$10.56
AVG Volume (30 Days)
174.8K
2.8M
Earning Date
02-17-2026
02-25-2026
Dividend Yield
2.18%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,789,200,000.00
$6,310,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.06
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$70.10
$1.05
52 Week High
$117.08
$6.02

Technical Indicators

Market Signals
Indicator
IOSP
TSHA
Relative Strength Index (RSI) 57.10 37.95
Support Level $79.41 $4.56
Resistance Level $82.36 $5.17
Average True Range (ATR) 1.89 0.34
MACD 0.14 -0.11
Stochastic Oscillator 65.23 0.39

Price Performance

Historical Comparison
IOSP
TSHA

About IOSP Innospec Inc.

Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Fuel Specialties segment, which generates the majority of revenue, sells products used to improve fuel efficiency, boost engine performance, and reduce emissions for automobiles, boats, and airplanes. It also sells products used by oil field service providers in the extraction of oil and gas. The Performance Chemicals segment sells products to the personal-care industry. The Oilfield Services segment develops and markets products to prevent loss of mud.

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

Share on Social Networks: